Work

Interstitial lung disease safety signal associated with canakinumab: insights from FAERS pharmacovigilance and network toxicology analysis

Year: 2026
Type: article
Abstract: Canakinumab is a monoclonal antibody targeting interleukin-1β (IL-1β). Although generally well tolerated, scattered reports of interstitial lung disease (ILD) have emerged. This study aimed to explore the potential association between canakinumab and ILD using real-world pharmacovigilance data, and to generate exploratory mechanistic hypotheses through network toxicology analysis. Adverse event reports from the FDA Adverse Event Reporting System (2009 Q2–2026 Q1) were analyzed using the reporting odds ratio and Bayesian information component, with subgroup analyses by indication and sex. Time-to-onset analysis with Weibull shape parameter testing characterized temporal patterns. Network toxicology analysis involved constructing a drug target pool centered on IL-1β, intersecting it with ILD-associated genes, and performing protein–protein interaction network analysis, hub gene identification, and functional enrichment. Among 19,000,026 unique reports, 123 canakinumab-associated ILD cases were identified, yielding a significant signal (ROR 2.10, 95% CI 1.76–2.51). The signal was present in the non-Still’s disease subgroup (ROR 1.43, 95% CI 1.13–1.81) but absent in Still’s disease patients (ROR 0.82, 95% CI 0.60–1.12). The median time to onset was 102.0 days overall with an early-onset Weibull pattern. Thirty-seven overlapping toxicity targets and ten hub genes were identified, forming an IL-1β-centered inflammatory network. Functional enrichment revealed dominant cytokine-mediated signaling, Toll-like receptor, NF-κB, and chemokine pathways, with no enrichment for TGF-β-driven fibrosis. A significant pharmacovigilance signal for ILD was identified in association with canakinumab exposure. Network toxicology analysis generated an exploratory hypothesis involving IL-1β-mediated pulmonary immune dysregulation. These findings warrant further investigation.
Language: English
Subfield: Toxicology
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7236670435
FWCI:
Cites:
Cited by:
Related to: 10